详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Liver transplantation following late-onset hepatic sinusoidal obstruction syndrome occurred beyond 1-year postallogeneic hematopoietic stem cell transplantation

133| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ ESCI

作者：

单位： [1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [2]Department of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

出处：

DOI：

ISSN：

关键词： hematopoietic stem cell transplantation late-onset hepatic sinusoidal obstruction syndrome liver transplantation

摘要：

Late-onset HOVD should be taken into consideration when patients develop liver dysfunction and/or weight gain no matter how long post-HSCT. Solid organ transplantation offers a valuable therapeutic option for selected patients with single organ failure after HSCT without adverse impact on graft function or overall outcomes.

基金：

语种：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

无

最新[2025]版：

大类 | 4 区医学

小类 | 4 区医学：内科

JCR分区：

出版当年[2021]版：

无

最新[2023]版：

Q3 MEDICINE, GENERAL & INTERNAL

影响因子： 0.6 最新[2023版] 0.6 最新五年平均 0 出版当年[2021版] 0 出版当年五年平均 0 出版前一年[2020版] 0.7 出版后一年[2022版]

第一作者：

第一作者单位： [1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

通讯作者：

通讯机构： [1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [*1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan 430030, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy [2][Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria]. [3]Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation? [4]CAR19/22 T cell cocktail therapy for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation [5]Epstein-Barr virus-associated NK-cell lymphoproliferative disorder treated with haploidentical hematopoietic stem cell transplantation [6]Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: Recent advances and modification [7]Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China [8]Pericardial effusion post transplantation predicts inferior overall survival following allo-hematopoietic stem cell transplant [9]Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation [10]Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation